Literature DB >> 8982336

Madindoline, a novel inhibitor of IL-6 activity from Streptomyces sp. K93-0711. I. Taxonomy, fermentation, isolation and biological activities.

M Hayashi1, Y P Kim, S Takamatsu, A Enomoto, M Shinose, Y Takahashi, H Tanaka, K Komiyama, S Omura.   

Abstract

Selective growth inhibition against IL-6-dependent cells was detected in fermentation extracts of a microbial strain, K93-0711, which was characterized as Streptomyces species. Active metabolite, termed madindoline A and B, were isolated, and the structure was determined to be 3a-hydroxy-indoline with diketocyclopentene at the N position. Madindoline A and B displayed dose-dependent inhibition of MH60 cells, an IL-6-dependent cell line, in presence of 0.1 U/ml IL-6. The IC50 for madindoline A and B against this cell line was 8 microM and 30 microM, respectively. These compounds did not inhibit the growth of cell lines which are not IL-6 dependent and the growth inhibition of the MH60 cell line was reversed by addition of excess, 0.4 U/ml, of IL-6 to the culture media. These compounds did not show any antimicrobial activity at a concentration of 1,000 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982336     DOI: 10.7164/antibiotics.49.1091

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130.

Authors:  Masahiko Hayashi; Mun-Chual Rho; Akiko Enomoto; Akiko Fukami; Yong-Pil Kim; Yuji Kikuchi; Toshiaki Sunazuka; Tomoyasu Hirose; Kanki Komiyama; Satoshi Omura
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

2.  Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes Treg development.

Authors:  S I Aqel; E E Kraus; N Jena; V Kumari; M C Granitto; L Mao; M F Farinas; E Y Zhao; G Perottino; W Pei; A E Lovett-Racke; M K Racke; J R Fuchs; C Li; Y Yang
Journal:  Clin Exp Immunol       Date:  2019-01-24       Impact factor: 4.330

3.  Synthesis of (+)-madindoline A and (+)-madindoline B.

Authors:  Lifeng Wan; Marcus A Tius
Journal:  Org Lett       Date:  2007-02-15       Impact factor: 6.005

4.  New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity.

Authors:  Veronika Talianová; Zdeněk Kejík; Robert Kaplánek; Kateřina Veselá; Nikita Abramenko; Lukáš Lacina; Karolína Strnadová; Barbora Dvořánková; Pavel Martásek; Michal Masařík; Magdalena Houdová Megová; Petr Bušek; Jana Křížová; Lucie Zdražilová; Hana Hansíková; Erik Vlčák; Vlada Filimonenko; Aleksi Šedo; Karel Smetana; Milan Jakubek
Journal:  Pharmaceutics       Date:  2022-08-17       Impact factor: 6.525

Review 5.  Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19.

Authors:  Jan Brábek; Milan Jakubek; Fréderic Vellieux; Jiří Novotný; Michal Kolář; Lukáš Lacina; Pavol Szabo; Karolína Strnadová; Daniel Rösel; Barbora Dvořánková; Karel Smetana
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.